{"title":"血脂异常。","authors":"Yamato Mashimo, T. Maeda, T. Teramoto","doi":"10.32388/9yfwq4","DOIUrl":null,"url":null,"abstract":"Low-density lipoprotein (LDL) cholesterol is the most established risk factor for atherosclerotic disease such as coronary artery disease and cerebrovascular disease. High-density lipoprotein (HDL) cholesterol and nonHDL-C as well as small dense LDL, Remnant like particles cholesterol (RLP-C) and oxidized LDL are the secondary risk factors for atherosclerosis. It is important to integrate and control these risk factors for the prevention of atherosclerosis as a real endpoint of diagnosis and treatment of dyslipidemia.","PeriodicalId":19307,"journal":{"name":"Nihon rinsho. Japanese journal of clinical medicine","volume":"55 1","pages":"852-6"},"PeriodicalIF":0.0000,"publicationDate":"2020-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Dyslipidemia].\",\"authors\":\"Yamato Mashimo, T. Maeda, T. Teramoto\",\"doi\":\"10.32388/9yfwq4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Low-density lipoprotein (LDL) cholesterol is the most established risk factor for atherosclerotic disease such as coronary artery disease and cerebrovascular disease. High-density lipoprotein (HDL) cholesterol and nonHDL-C as well as small dense LDL, Remnant like particles cholesterol (RLP-C) and oxidized LDL are the secondary risk factors for atherosclerosis. It is important to integrate and control these risk factors for the prevention of atherosclerosis as a real endpoint of diagnosis and treatment of dyslipidemia.\",\"PeriodicalId\":19307,\"journal\":{\"name\":\"Nihon rinsho. Japanese journal of clinical medicine\",\"volume\":\"55 1\",\"pages\":\"852-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-02-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nihon rinsho. Japanese journal of clinical medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32388/9yfwq4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nihon rinsho. Japanese journal of clinical medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32388/9yfwq4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Low-density lipoprotein (LDL) cholesterol is the most established risk factor for atherosclerotic disease such as coronary artery disease and cerebrovascular disease. High-density lipoprotein (HDL) cholesterol and nonHDL-C as well as small dense LDL, Remnant like particles cholesterol (RLP-C) and oxidized LDL are the secondary risk factors for atherosclerosis. It is important to integrate and control these risk factors for the prevention of atherosclerosis as a real endpoint of diagnosis and treatment of dyslipidemia.